Abstract:Rationale: Cell reprogramming technology is utilized to prevent cancer progression by transforming cells into terminally differentiated, non-proliferating states. Polypyrimidine tract binding protein 1 (PTBP1) is an RNA binding protein required for the growth of neurons and may directly transform multiple normal human cells into functioning neurons in vitro and in vivo when expressed at low levels. As a result, we identified it as a key to inhibiting cancer cell proliferation by boosting glioblastoma cell neural differentiation. Methods: Immunocytofluorescence (ICF) targeting TUJ1, MAP2, KI67, and EdU were utilized to evaluate glioblastoma cell reprogramming under PTBP1 knockdown or other conditions. PTBP1 and other target genes were detected using Western blotting and qRT-PCR. Activating protein phosphatase 2A (PP2A) and RhoA were detected using specific kits. CCK8 assays were employed to detect cell viability. Bioluminescence, immunohistofluorescence (IHF), and Kaplan-Meier survival analyses were utilized to demonstrate the in vivo reprogramming efficiency of PTBP1 knockdown in U87 murine glioblastoma model. In this study, RNA-seq technology was used to examine the intrinsic pathway. Results: The expression of TUJ1 and MAP2 neural markers, as well as the absence of KI67 and EdU proliferative markers in U251, U87, and KNS89 cells, indicated that glioblastoma cell reprogramming was successful. In vivo, U87 growth generated xenografts was substantially shrank due to PTBP1 knockdown induced neural differentiation, and these tumor-bearing mice had a prolonged survival time. Following RNA-seq, ten potential downstream genes were eliminated. Lentiviral interference and inhibitors blocking tests demonstrated that UNC5B receptor and its downstream signaling were essential in the neural differentiation process mediated by PTBP1 knockdown in glioblastoma cells. Conclusions: Our results indicate that PTBP1 knockdown promotes neural differentiation of glioblastoma cells via UNC5B receptor, consequently suppressing cancer cell proliferation in vitro and in vivo, providing a promising and feasible approach for glioblastoma treatment.

Genetic loss of function of Ptbp1 does not induce glia-to-neuron conversion in retina

Robust reprogramming of glia into neurons by inhibition of Notch signaling and nuclear factor I (NFI) factors in adult mammalian retina

Downregulating PTBP1 Fails to Convert Astrocytes into Hippocampal Neurons and to Alleviate Symptoms in Alzheimer's Mouse Models.

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Repressing PTBP1 Fails to Convert Reactive Astrocytes to Dopaminergic Neurons in a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease

Repressing PTBP1 is Incapable to Convert Reactive Astrocytes to Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

Ptbp1 knockdown failed to induce astrocytes to neurons in vivo

NeuroD1 induces microglial apoptosis and cannot induce microglia-to-neuron cross-lineage reprogramming

Reducing Polypyrimidine Tract‑binding Protein 1 Fails to Promote Neuronal Transdifferentiation on HT22 and Mouse Astrocyte Cells under Physiological Conditions.

Re-activation of neurogenic niches in aging brain

New AAV tools fail to detect Neurod1-mediated neuronal conversion of Müller glia and astrocytes in vivo

Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB

Viral-mediated Oct4 overexpression and inhibition of Notch signaling synergistically induce neurogenic competence in mammalian Müller glia

Viral-mediated Oct4 overexpression and inhibition of Notch signaling synergistically induce neurogenic competence in mammalian Muller glia.

Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits

Reprogramming Müller glia to regenerate ganglion-like cells in adult mouse retina with developmental transcription factors

Overexpressing NeuroD1 Reprograms Müller Cells into Various Types of Retinal Neurons.

PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor

Neuronal conversion from glia to replenish the lost neurons

Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes

Turning Reactive Glia into Functional Neurons in the Brain.